Latest Articles
Deep learning for endometrial cancer subtyping and predicting tumor mutational burden from histopathological slides - Nature.com
Deep learning for endometrial cancer subtyping and predicting tumor mutational burden from histopathological slides Nature.com
Published: Dec. 21, 2024, 9:20 a.m.
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer - Nature.com
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer Nature.com
Published: Dec. 20, 2024, 10:34 a.m.
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors - Medpage Today
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors Medpage Today
Published: Dec. 18, 2024, 8:16 p.m.
ASCO Reading Room | The Evolving Treatment Landscape for High-Risk Endometrial Cancer - Medpage Today
ASCO Reading Room | The Evolving Treatment Landscape for High-Risk Endometrial Cancer Medpage Today
Published: Dec. 18, 2024, 3:59 p.m.
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer - Medpage Today
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer Medpage Today
Published: Dec. 18, 2024, 3:27 p.m.
GSK’s Jemperli receives positive CHMP opinion for expanded endometrial cancer use - PMLiVE
GSK’s Jemperli receives positive CHMP opinion for expanded endometrial cancer use PMLiVE
Published: Dec. 18, 2024, 12:25 p.m.
Molecular Classification Drives Advances in Endometrial Cancer Treatment - Journal of Clinical Pathways
Molecular Classification Drives Advances in Endometrial Cancer Treatment Journal of Clinical Pathways
Published: Dec. 17, 2024, 3:25 p.m.
GSK's Jemperli receives positive CHMP opinion for endometrial cancer - Investing.com India
GSK's Jemperli receives positive CHMP opinion for endometrial cancer Investing.com India
Published: Dec. 16, 2024, 7:47 p.m.
GSK's Jemperli receives positive CHMP opinion for endometrial cancer - Investing.com
GSK's Jemperli receives positive CHMP opinion for endometrial cancer Investing.com
Published: Dec. 16, 2024, 5:30 p.m.
Different surgical methods of hysterectomy for the management of endometrial cancer: A systematic review and network meta-analysis - Frontiers
Different surgical methods of hysterectomy for the management of endometrial cancer: A systematic review and network meta-analysis Frontiers
Published: Dec. 16, 2024, 4:23 p.m.
Link copied to clipboard!